Publication:
Cost-of-illness studies in rare diseases: a scoping review

Loading...
Thumbnail Image
Identifiers

Publication date

Advisors

Journal Title

Journal ISSN

Volume Title

Publishers

BioMed Central (BMC)
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Objective: The aim of this scoping review was to overview the cost-of-illness studies conducted in rare diseases. Methods: We searched papers published in English in PubMed from January 2007 to December 2018. We selected cost-of-illness studies on rare diseases defined as those with prevalence lower than 5 per 10,000 cases. Studies were selected by one researcher and verified by a second researcher. Methodological characteristics were extracted to develop a narrative synthesis. Results: We included 63 cost-of-illness studies on 42 rare diseases conducted in 25 countries, and 9 systematic reviews. Most studies (94%) adopted a prevalence-based estimation, where the predominant design was cross-sectional with a bottom-up approach. Only four studies adopted an incidence-based estimation. Most studies used questionnaires to patients or caregivers to collect resource utilisation data (67%) although an important number of studies used databases or registries as a source of data (48%). Costs of lost productivity, non-medical costs and informal care costs were included in 68%, 60% and 43% of studies, respectively. Conclusion: This review found a paucity of cost-of-illness studies in rare diseases. However, the analysis shows that the cost-of-illness studies of rare diseases are feasible, although the main issue is the lack of primary and/or aggregated data that often prevents a reliable estimation of the economic burden.

Description

MeSH Terms

DeCS Terms

Bibliographic citation

Orphanet J Rare Dis . 2021 Apr 13;16(1):178.

Related dataset

Related publication

Document type